Press Releases

EndoBarrier® Therapy Receives OPS Codes in Germany and Switzerland

LEXINGTON, Massachusetts & SYDNEY, Australia – 1 October 2013 – GI Dynamics, Inc. (ASX: GID) announced today that the German Institute of Medical Documentation and Information (DMDI) has designated preliminary OPS codes (Operationen- and Prozedurenschlussel) to EndoBarrier® Therapy which is...

read more

GI Dynamics, Inc. Provides Update on Progress of the ENDO Trial

LEXINGTON, Massachusetts & SYDNEY – 12 September 2013 – GI Dynamics, Inc. (ASX: GID) today announced an update on the progress of the ENDO Trial, its U.S. multi-center, pivotal clinical trial of EndoBarrier® for the treatment of patients who have uncontrolled type 2 diabetes and obesity. To...

read more

GI Dynamics, Inc. Appoints Distributor for the Middle East

LEXINGTON, Massachusetts and SYDNEY, Australia – 26 June 2013 – GI Dynamics, Inc. (ASX: GID) today announced that it has appointed Al-Nozha Medical Est., based in Jeddah, Saudi Arabia, as the distributor of EndoBarrier®, GI Dynamics’ proprietary treatment for type 2 diabetes and/or obesity, in...

read more
Page 12 of 20« First...1011121314...20...Last »